Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Scripps Research scientists uncover plausible pathway for protocell formation

Scripps Research scientists uncover plausible pathway for protocell formation

UB research may offer a more streamlined approach to developing cancer drugs

UB research may offer a more streamlined approach to developing cancer drugs

Bio-Hermes data reveals strong correlation between blood biomarkers and Alzheimer's amyloid plaques

Bio-Hermes data reveals strong correlation between blood biomarkers and Alzheimer's amyloid plaques

Novel "Tissue-in-a-CUBE" model mimics blood-brain barrier for drug testing

Novel "Tissue-in-a-CUBE" model mimics blood-brain barrier for drug testing

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Optibrium enables collaborative design in its StarDrop platform

Optibrium enables collaborative design in its StarDrop platform

SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry

SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry

Machine learning enhances understanding of drug absorption

Machine learning enhances understanding of drug absorption

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Cellectricon’s expertise in pain research recognized by second EU research grant

Cellectricon’s expertise in pain research recognized by second EU research grant

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

New standards for evaluating aging biomarkers unveiled

New standards for evaluating aging biomarkers unveiled

Novel synthetic antibiotic effective against drug-resistant bacteria

Novel synthetic antibiotic effective against drug-resistant bacteria

Breaking through new research barriers with iPSC technology

Breaking through new research barriers with iPSC technology

New AI tool revolutionizes protein function prediction

New AI tool revolutionizes protein function prediction

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Rucaparib and its major metabolite exhibit differential biological activity and synergy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.